Shuttle Pharmaceuticals Holdings, Inc. financial data

Symbol
SHPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Professional Drive, Suite 260, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Sep 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 412 % -57%
Debt-to-equity 58 % +135%
Return On Equity -218 % -137%
Return On Assets -138 % -86.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.23M shares -86.1%
Common Stock, Shares, Outstanding 2.11M shares -86.4%
Entity Public Float 11.7M USD
Common Stock, Value, Issued 21 USD -86.5%
Weighted Average Number of Shares Outstanding, Basic 2.1M shares +18.2%
Weighted Average Number of Shares Outstanding, Diluted 2.1M shares +18.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.99M USD +23%
General and Administrative Expense 1.22M USD +32.9%
Operating Income (Loss) -5.75M USD -31.8%
Nonoperating Income (Expense) -1.45M USD +42.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.78M USD -77.8%
Net Income (Loss) Attributable to Parent -7.2M USD -4.64%
Earnings Per Share, Basic -3.52 USD/shares +47.5%
Earnings Per Share, Diluted -3.52 USD/shares +22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 696K USD -87.2%
Marketable Securities, Current 1.64M USD -43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 5.95K USD
Other Assets, Current 81.5K USD
Assets, Current 2.49M USD -70.6%
Property, Plant and Equipment, Net 22K USD +128%
Operating Lease, Right-of-Use Asset 306K USD -20.4%
Other Assets, Noncurrent 6.48K USD
Assets 2.81M USD -68.2%
Liabilities, Current 1.38M USD +180%
Operating Lease, Liability, Noncurrent 267K USD -19%
Liabilities 2.01M USD +5.79%
Retained Earnings (Accumulated Deficit) -29.2M USD -142%
Stockholders' Equity Attributable to Parent 801K USD -88.4%
Liabilities and Equity 2.81M USD -68.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.24M USD +7.39%
Net Cash Provided by (Used in) Financing Activities -40K USD -101%
Net Cash Provided by (Used in) Investing Activities 101K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.11M shares -86.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.18M USD +5.62%
Interest Paid, Excluding Capitalized Interest, Operating Activities 79K USD
Deferred Tax Assets, Valuation Allowance 3.38M USD +161%
Deferred Tax Assets, Gross 3.43M USD +145%
Operating Lease, Liability 329K USD
Depreciation 1.91K USD +28.5%
Lessee, Operating Lease, Liability, to be Paid 406K USD
Property, Plant and Equipment, Gross 127K USD
Operating Lease, Liability, Current 62.1K USD +1.73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 97.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 94.2K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 76.7K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.73M USD +130%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 68.2K USD
Operating Lease, Payments 22.7K USD -2.68%
Additional Paid in Capital 30M USD +58%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%